| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/23/2003 | WO2002070002A9 Methods for regulation of immune responses to conditions involving mediator-induced pathology |
| 01/23/2003 | WO2002066509A3 Treatment involving dkk-1 or antagonists thereof |
| 01/23/2003 | WO2002053711A3 Use of transcription factor yb-1 in adenoviral systems |
| 01/23/2003 | WO2002050302A3 Protein-protein interactions |
| 01/23/2003 | WO2002050294A9 A novel tissue specific plant promoter |
| 01/23/2003 | WO2002048313A3 Senescence-associated plant promotors |
| 01/23/2003 | WO2002047466A3 Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof |
| 01/23/2003 | WO2002046400A3 Mutated class ii major histocompatibility proteins |
| 01/23/2003 | WO2002046364A9 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 01/23/2003 | WO2002044391A3 Methods and compositions for the introduction of molecules into cells |
| 01/23/2003 | WO2002042435A3 Regulation of human tyrosine phosphatase |
| 01/23/2003 | WO2002040651A3 A human trna-specific adenosine deaminase |
| 01/23/2003 | WO2002040498A3 Reduction of antioxidant enzyme levels in tumor cells using antisense oligonucleotides |
| 01/23/2003 | WO2002036790A3 Influenza virus vector for infection of dendritic cells |
| 01/23/2003 | WO2002036767A3 Therapeutic oligonucleotides of reduced toxicity |
| 01/23/2003 | WO2002036741A3 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 01/23/2003 | WO2002034927A3 Plant genes that confer resistance to strains of magnaporthe grisea having avr1 co39 cultivar specificity gene |
| 01/23/2003 | WO2002034921A3 FERMENTATIVE PRODUCTION OF D-p-HYDROXYPHENYLGLYCINE AND D-PHENYLGLYCINE |
| 01/23/2003 | WO2002034778A3 Baseb209 polypeptides and polynucleotides from haemophilus influenzae |
| 01/23/2003 | WO2002034768A3 Polypeptides and polynucleodides from haemophilus influenzae and their use |
| 01/23/2003 | WO2002033095A3 Regulation of human serine-threonine protein kinase |
| 01/23/2003 | WO2002031162A3 Regulation of human phospholipase a2-like enzyme |
| 01/23/2003 | WO2002030457A3 Microbes having an attenuating mutation comprising a transcription terminator |
| 01/23/2003 | WO2002029059A3 Nogo receptor homologs |
| 01/23/2003 | WO2002029057A3 32144, a human fatty acid amide hydrolase and uses thereof |
| 01/23/2003 | WO2002028903A3 Heavy chain libraries |
| 01/23/2003 | WO2002026999A3 Regulation of human adam-ts-like protein |
| 01/23/2003 | WO2002026986A3 Identification and cloning of a full-length human cink-related gene, mist (mast cell immunoreceptor signal transducer) |
| 01/23/2003 | WO2002026834A3 32624 a novel human udp-glucuronosyl and glycosyl transferase family member and uses thereof |
| 01/23/2003 | WO2002024906A9 Induction of exon skipping in eukaryotic cells |
| 01/23/2003 | WO2002024739A3 Spas-1 cancer antigen |
| 01/23/2003 | WO2002024325A3 Acoustic ejection of fluids from a plurality of reservoirs |
| 01/23/2003 | WO2002020796A3 Methanotrophic carbon metabolism pathway genes and enzymes |
| 01/23/2003 | WO2002020773A3 Chimeric antisense oligonucleotides of arabinofuranose analogues and deoxyribose nucleotides |
| 01/23/2003 | WO2002020619A3 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 01/23/2003 | WO2002020569A3 Mammalian genes; related reagents and methods |
| 01/23/2003 | WO2002018585A3 Packaging of positive-strand rna virus replicon particles |
| 01/23/2003 | WO2002018574A3 Human interleukin-four induced protein |
| 01/23/2003 | WO2002016601A3 Microorganisms and assays for the identification of antibiotics |
| 01/23/2003 | WO2002016598A3 Nucleic acid and corresponding protein named 158p1h4 useful in the treatment and detection of bladder and other cancers |
| 01/23/2003 | WO2002016583A3 Constructs and their use in metabolic pathway engineering |
| 01/23/2003 | WO2002016553A3 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 01/23/2003 | WO2002014523A3 Methods for stable transformation of plants |
| 01/23/2003 | WO2002014364A3 Rattlesnake venom gland proteins |
| 01/23/2003 | WO2002012272A3 Therapeutic anti-melanoma compounds |
| 01/23/2003 | WO2002010418A3 Targeting through integrins |
| 01/23/2003 | WO2002010412A3 Novel regulatory genes involved in condensed tannin synthesis in plants |
| 01/23/2003 | WO2002010405A3 A human disintegrin protein |
| 01/23/2003 | WO2002010363A3 Protein phosphatases |
| 01/23/2003 | WO2002010204A3 G protein-coupled receptors |
| 01/23/2003 | WO2002008415A1 METHOD OF SCREENING PTPz ACTIVITY PROMOTER OR INHIBITOR |
| 01/23/2003 | WO2002008397A3 A human atpase and uses therefor |
| 01/23/2003 | WO2002008293A3 Multivalent target binding protein |
| 01/23/2003 | WO2002006330A3 13237,18480,2245 or 16228 human protein kinase molecules and uses therefor |
| 01/23/2003 | WO2002004022A9 High fidelity polymerases and uses thereof |
| 01/23/2003 | WO2002002771A3 Human sparc-homologous (hsparc-h1) gene and methods and uses thereof |
| 01/23/2003 | WO2002000904A3 Recombinant constructs and their use in reducing gene expression |
| 01/23/2003 | WO2002000720A3 Novel human gaba receptors and polynucleotides encoding the same |
| 01/23/2003 | WO2001096584A3 Materials and methods for the control of nematodes |
| 01/23/2003 | WO2001093851A3 Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3 |
| 01/23/2003 | WO2001090358A3 Mammalian receptor proteins; related reagents and methods |
| 01/23/2003 | WO2001090337A3 Detection of rna |
| 01/23/2003 | WO2001090333A3 Recombinant bacterial phytases and uses thereof |
| 01/23/2003 | WO2001089583A3 Glutamic acid decarboxylase (gad)_delivery system for treating neurodegenerative diseases |
| 01/23/2003 | WO2001089364A3 Hcv variants |
| 01/23/2003 | WO2001088124A3 Method and reagent for the inhibition of erg |
| 01/23/2003 | WO2001083824A3 Polynucleotide probes for detection and quantitation of candida albicans and candida dubliniensis |
| 01/23/2003 | WO2001083782A3 Novel proteases |
| 01/23/2003 | WO2001079467A3 Identification of a renal nadph oxidase |
| 01/23/2003 | WO2001077334A9 Lactococcus lactis genome, polypeptides and uses |
| 01/23/2003 | WO2001077311A3 Transcription factor stress-related proteins and methods of use in plants |
| 01/23/2003 | WO2001075174A3 Detection and typing of human papillomavirus using pna probes |
| 01/23/2003 | WO2001073031A3 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/23/2003 | WO2001072768A3 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same |
| 01/23/2003 | WO2001066568A3 Use of recombinant antigens to determine the immune status of an animal |
| 01/23/2003 | WO2001053520A3 Gene chip for neonate screening |
| 01/23/2003 | WO2001023606A9 Nucleic acid molecules for detecting bacteria and phylogenetic units of bacteria |
| 01/23/2003 | WO2001007647A9 Method for relative quantization of methylation of cytosin-type bases in dna samples |
| 01/23/2003 | US20030018997 Nucleotide sequences for use in reducing nicotine concentration in tobacco |
| 01/23/2003 | US20030018995 Plants with a modified flower and seed development |
| 01/23/2003 | US20030018994 Nucleotide sequences for use in the regulation of heterologous gene expression |
| 01/23/2003 | US20030018993 Methods of gene silencing using inverted repeat sequences |
| 01/23/2003 | US20030018992 Providing a seed for the transgenic corn plant which seed comprises a transgenic event having activity against at least one of the one or more pests; treating the seed with an effective amount of a pesticide |
| 01/23/2003 | US20030018990 Cabbage proteinase inhibitor gene confers resistance against plant pests |
| 01/23/2003 | US20030018989 Animal model for use in the treatment and diagnosis of hyperactivity disorders |
| 01/23/2003 | US20030018988 Animal model for use in the diagnosis and treatment of epileptic and nervous system disorders |
| 01/23/2003 | US20030018987 Animal model for use in the diagnosis and treatment of eating, apoptosis and infectious disorders |
| 01/23/2003 | US20030018986 Polynucleotide |
| 01/23/2003 | US20030018985 Nucleotide sequences coding enzymatic polypeptide for use in the generation of preferential amino acid in plant seeds |
| 01/23/2003 | US20030018984 IGF-I expression system and methods of use |
| 01/23/2003 | US20030018349 Nucleic acid molecules specific for bacterial antigens and uses thereof |
| 01/23/2003 | US20030018184 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 01/23/2003 | US20030018181 Antiinflammatory agents; culturing; isolation of fusion protein |
| 01/23/2003 | US20030018180 Secreted protein HFEAF41 |
| 01/23/2003 | US20030018178 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/23/2003 | US20030018177 Method for nucleic acid isolation and kit |
| 01/23/2003 | US20030018165 Uses of suppressive macrophage activation factors |
| 01/23/2003 | US20030018007 Compositions and methods for inducing gene expression |
| 01/23/2003 | US20030018005 Autoimmune disease; antiinflammatory agents; antiallergens; rheumatic diseases; antitumor agents |
| 01/23/2003 | US20030018004 Vector |